Exact Mass: 527.2889736000001
Exact Mass Matches: 527.2889736000001
Found 500 metabolites which its exact mass value is equals to given mass value 527.2889736000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z))
LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/22:5(4Z,7Z,10Z,13Z,16Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(0:0/22:5(7Z,10Z,13Z,16Z,19Z))
LysoPE(0:0/22:5(7Z,10Z,13Z,16Z,19Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/22:5(7Z,10Z,13Z,16Z,19Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
LysoPE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(22:5(4Z,7Z,10Z,13Z,16Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(22:5(7Z,10Z,13Z,16Z,19Z)/0:0)
LysoPE(22:5(7Z,10Z,13Z,16Z,19Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(22:5(7Z,10Z,13Z,16Z,19Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
Doramapimod
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM[1][2].
(1S*,3aS*,4S*,5S*,7S*,7aS*)-1-benzyloctahydro-5-hydroxy-4-[(1E,4S)-6-hydroxy-4,6-dimethyl-5,8-dioxooct-1-en-1-yl]-7-methyl-6-methylidene-3-oxo-3aH-isoindol-3a-yl methyl carbonate|cytochalasin Z19
(27R)-26,27-dihydro-virginiamycin-M1|(32R,6R,8E,13E,15E)-17t-hydroxy-6r-isopropyl-7c,15-dimethyl-5-oxa-11-aza-1(4,2)-oxazola-3(1,2)-pyrrolidina-cycloeicosaphane-8,13,15-triene-2,4,10,19-tetraone|23,35-ethane-1,2-diyl-madumycin-I|ostreogrycin-G|Pristinamycin|pristinamycin-IIB|virginiamycin-M2
C28H37N3O7 (527.2631372000001)
12,13-epoxy-11-deoxo-6-oxo-5alpha,6-dihydrojervine N,O-diacetate
Doramapimod
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2149 - Mitogen-Activated Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM[1][2].
2-((4R)-4-((3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2,2-dimethylpentanamido)ethane-1-sulfonic acid
C28H49NO6S (527.3280414000001)
Ala Phe Lys Tyr
Ala Phe Tyr Lys
Ala Lys Phe Tyr
Ala Lys Tyr Phe
Ala Tyr Phe Lys
Ala Tyr Lys Phe
Cys His Ile Arg
Cys His Leu Arg
Cys His Arg Ile
Cys His Arg Leu
Cys Ile His Arg
Cys Ile Arg His
Cys Leu His Arg
Cys Leu Arg His
Cys Arg His Ile
Cys Arg His Leu
Cys Arg Ile His
Cys Arg Leu His
Asp His Arg Thr
Asp His Thr Arg
Asp Arg His Thr
Asp Arg Thr His
Asp Thr His Arg
Asp Thr Arg His
Glu His Arg Ser
Glu His Ser Arg
Glu Arg His Ser
Glu Arg Ser His
Glu Ser His Arg
Glu Ser Arg His
Phe Ala Lys Tyr
Phe Ala Tyr Lys
Phe Phe Lys Ser
Phe Phe Ser Lys
Phe His Lys Pro
Phe His Pro Lys
Phe His Pro Gln
Phe His Gln Pro
Phe Lys Ala Tyr
Phe Lys Phe Ser
Phe Lys His Pro
Phe Lys Pro His
Phe Lys Ser Phe
Phe Lys Tyr Ala
Phe Pro His Lys
Phe Pro His Gln
Phe Pro Lys His
Phe Pro Gln His
Phe Gln His Pro
Phe Gln Pro His
Phe Ser Phe Lys
Phe Ser Lys Phe
Phe Tyr Ala Lys
Phe Tyr Lys Ala
His Cys Ile Arg
His Cys Leu Arg
His Cys Arg Ile
His Cys Arg Leu
His Asp Arg Thr
His Asp Thr Arg
His Glu Arg Ser
His Glu Ser Arg
His Phe Lys Pro
His Phe Pro Lys
His Phe Pro Gln
His Phe Gln Pro
His Ile Cys Arg
His Ile Lys Met
C23H41N7O5S (527.2889736000001)
His Ile Met Lys
C23H41N7O5S (527.2889736000001)
His Ile Met Gln
His Ile Gln Met
His Ile Arg Cys
His Lys Phe Pro
His Lys Ile Met
C23H41N7O5S (527.2889736000001)
His Lys Leu Met
C23H41N7O5S (527.2889736000001)
His Lys Met Ile
C23H41N7O5S (527.2889736000001)
His Lys Met Leu
C23H41N7O5S (527.2889736000001)
His Lys Pro Phe
His Leu Cys Arg
His Leu Lys Met
C23H41N7O5S (527.2889736000001)
His Leu Met Lys
C23H41N7O5S (527.2889736000001)
His Leu Met Gln
His Leu Gln Met
His Leu Arg Cys
His Met Ile Lys
C23H41N7O5S (527.2889736000001)
His Met Ile Gln
His Met Lys Ile
C23H41N7O5S (527.2889736000001)
His Met Lys Leu
C23H41N7O5S (527.2889736000001)
His Met Leu Lys
C23H41N7O5S (527.2889736000001)
His Met Leu Gln
His Met Gln Ile
His Met Gln Leu
His Pro Phe Lys
His Pro Phe Gln
His Pro Lys Phe
His Pro Gln Phe
His Gln Phe Pro
His Gln Ile Met
His Gln Leu Met
His Gln Met Ile
His Gln Met Leu
His Gln Pro Phe
His Arg Cys Ile
His Arg Cys Leu
His Arg Ile Cys
His Arg Leu Cys
His Ser Val Trp
His Ser Trp Val
His Val Ser Trp
His Val Trp Ser
His Trp Ser Val
His Trp Val Ser
Ile Cys His Arg
Ile Cys Arg His
Ile His Cys Arg
Ile His Lys Met
C23H41N7O5S (527.2889736000001)
Ile His Met Lys
C23H41N7O5S (527.2889736000001)
Ile His Met Gln
Ile His Gln Met
Ile His Arg Cys
Ile Ile Pro Trp
Ile Ile Trp Pro
Ile Lys His Met
C23H41N7O5S (527.2889736000001)
Ile Lys Met His
C23H41N7O5S (527.2889736000001)
Ile Leu Pro Trp
Ile Leu Trp Pro
Ile Met His Lys
C23H41N7O5S (527.2889736000001)
Ile Met His Gln
Ile Met Lys His
C23H41N7O5S (527.2889736000001)
Ile Met Gln His
Ile Pro Ile Trp
Ile Pro Leu Trp
Ile Pro Trp Ile
Ile Pro Trp Leu
Ile Gln His Met
Ile Gln Met His
Ile Arg Cys His
Ile Arg His Cys
Ile Trp Ile Pro
Ile Trp Leu Pro
Ile Trp Pro Ile
Ile Trp Pro Leu
Lys Ala Phe Tyr
Lys Ala Tyr Phe
Lys Phe Ala Tyr
Lys Phe Phe Ser
Lys Phe His Pro
Lys Phe Pro His
Lys Phe Ser Phe
Lys Phe Tyr Ala
Lys His Phe Pro
Lys His Ile Met
C23H41N7O5S (527.2889736000001)
Lys His Leu Met
C23H41N7O5S (527.2889736000001)
Lys His Met Ile
C23H41N7O5S (527.2889736000001)
Lys His Met Leu
C23H41N7O5S (527.2889736000001)
Lys His Pro Phe
Lys Ile His Met
C23H41N7O5S (527.2889736000001)
Lys Ile Met His
C23H41N7O5S (527.2889736000001)
Lys Leu His Met
C23H41N7O5S (527.2889736000001)
Lys Leu Met His
C23H41N7O5S (527.2889736000001)
Lys Met His Ile
C23H41N7O5S (527.2889736000001)
Lys Met His Leu
C23H41N7O5S (527.2889736000001)
Lys Met Ile His
C23H41N7O5S (527.2889736000001)
Lys Met Leu His
C23H41N7O5S (527.2889736000001)
Lys Pro Phe His
Lys Pro His Phe
Lys Pro Gln Arg
C22H41N9O6 (527.3179646000001)
Lys Pro Arg Gln
C22H41N9O6 (527.3179646000001)
Lys Gln Pro Arg
C22H41N9O6 (527.3179646000001)
Lys Gln Arg Pro
C22H41N9O6 (527.3179646000001)
Lys Arg Pro Gln
C22H41N9O6 (527.3179646000001)
Lys Arg Gln Pro
C22H41N9O6 (527.3179646000001)
Lys Ser Phe Phe
Lys Tyr Ala Phe
Lys Tyr Phe Ala
Leu Cys His Arg
Leu Cys Arg His
Leu His Cys Arg
Leu His Lys Met
C23H41N7O5S (527.2889736000001)
Leu His Met Lys
C23H41N7O5S (527.2889736000001)
Leu His Met Gln
Leu His Gln Met
Leu His Arg Cys
Leu Ile Pro Trp
Leu Ile Trp Pro
Leu Lys His Met
C23H41N7O5S (527.2889736000001)
Leu Lys Met His
C23H41N7O5S (527.2889736000001)
Leu Leu Pro Trp
Leu Leu Trp Pro
Leu Met His Lys
C23H41N7O5S (527.2889736000001)
Leu Met His Gln
Leu Met Lys His
C23H41N7O5S (527.2889736000001)
Leu Met Gln His
Leu Pro Ile Trp
Leu Pro Leu Trp
Leu Pro Trp Ile
Leu Pro Trp Leu
Leu Gln His Met
Leu Gln Met His
Leu Arg Cys His
Leu Arg His Cys
Leu Trp Ile Pro
Leu Trp Leu Pro
Leu Trp Pro Ile
Leu Trp Pro Leu
Met His Ile Lys
C23H41N7O5S (527.2889736000001)
Met His Ile Gln
Met His Lys Ile
C23H41N7O5S (527.2889736000001)
Met His Lys Leu
C23H41N7O5S (527.2889736000001)
Met His Leu Lys
C23H41N7O5S (527.2889736000001)
Met His Leu Gln
Met His Gln Ile
Met His Gln Leu
Met Ile His Lys
C23H41N7O5S (527.2889736000001)
Met Ile His Gln
Met Ile Lys His
C23H41N7O5S (527.2889736000001)
Met Ile Gln His
Met Lys His Ile
C23H41N7O5S (527.2889736000001)
Met Lys His Leu
C23H41N7O5S (527.2889736000001)
Met Lys Ile His
C23H41N7O5S (527.2889736000001)
Met Lys Leu His
C23H41N7O5S (527.2889736000001)
Met Leu His Lys
C23H41N7O5S (527.2889736000001)
Met Leu His Gln
Met Leu Lys His
C23H41N7O5S (527.2889736000001)
Met Leu Gln His
Met Gln His Ile
Met Gln His Leu
Met Gln Ile His
Met Gln Leu His
Pro Phe His Lys
Pro Phe His Gln
Pro Phe Lys His
Pro Phe Gln His
Pro His Phe Lys
Pro His Phe Gln
Pro His Lys Phe
Pro His Gln Phe
Pro Ile Ile Trp
Pro Ile Leu Trp
Pro Ile Trp Ile
Pro Ile Trp Leu
Pro Lys Phe His
Pro Lys His Phe
Pro Lys Gln Arg
C22H41N9O6 (527.3179646000001)
Pro Lys Arg Gln
C22H41N9O6 (527.3179646000001)
Pro Leu Ile Trp
Pro Leu Leu Trp
Pro Leu Trp Ile
Pro Leu Trp Leu
Pro Gln Phe His
Pro Gln His Phe
Pro Gln Lys Arg
C22H41N9O6 (527.3179646000001)
Pro Gln Gln Arg
Pro Gln Arg Lys
C22H41N9O6 (527.3179646000001)
Pro Gln Arg Gln
Pro Arg Lys Gln
C22H41N9O6 (527.3179646000001)
Pro Arg Gln Lys
C22H41N9O6 (527.3179646000001)
Pro Arg Gln Gln
Pro Trp Ile Ile
Pro Trp Ile Leu
Pro Trp Leu Ile
Pro Trp Leu Leu
Gln Phe His Pro
Gln Phe Pro His
Gln His Phe Pro
Gln His Ile Met
Gln His Leu Met
Gln His Met Ile
Gln His Met Leu
Gln His Pro Phe
Gln Ile His Met
Gln Ile Met His
Gln Lys Pro Arg
C22H41N9O6 (527.3179646000001)
Gln Lys Arg Pro
C22H41N9O6 (527.3179646000001)
Gln Leu His Met
Gln Leu Met His
Gln Met His Ile
Gln Met His Leu
Gln Met Ile His
Gln Met Leu His
Gln Pro Phe His
Gln Pro His Phe
Gln Pro Lys Arg
C22H41N9O6 (527.3179646000001)
Gln Pro Gln Arg
Gln Pro Arg Lys
C22H41N9O6 (527.3179646000001)
Gln Pro Arg Gln
Gln Gln Pro Arg
Gln Gln Arg Pro
Gln Arg Lys Pro
C22H41N9O6 (527.3179646000001)
Gln Arg Pro Lys
C22H41N9O6 (527.3179646000001)
Gln Arg Pro Gln
Gln Arg Gln Pro
Arg Cys His Ile
Arg Cys His Leu
Arg Cys Ile His
Arg Cys Leu His
Arg His Cys Ile
Arg His Cys Leu
Arg His Ile Cys
Arg His Leu Cys
Arg Ile Cys His
Arg Ile His Cys
Arg Lys Pro Gln
C22H41N9O6 (527.3179646000001)
Arg Lys Gln Pro
C22H41N9O6 (527.3179646000001)
Arg Leu Cys His
Arg Leu His Cys
Arg Pro Lys Gln
C22H41N9O6 (527.3179646000001)
Arg Pro Gln Lys
C22H41N9O6 (527.3179646000001)
Arg Pro Gln Gln
Arg Gln Lys Pro
C22H41N9O6 (527.3179646000001)
Arg Gln Pro Lys
C22H41N9O6 (527.3179646000001)
Arg Gln Pro Gln
Arg Gln Gln Pro
Ser Phe Phe Lys
Ser Phe Lys Phe
Ser His Val Trp
Ser His Trp Val
Ser Lys Phe Phe
Ser Val His Trp
Ser Val Trp His
Ser Trp His Val
Ser Trp Val His
Val His Ser Trp
Val His Trp Ser
Val Ser His Trp
Val Ser Trp His
Val Trp His Ser
Val Trp Ser His
Trp His Ser Val
Trp His Val Ser
Trp Ile Ile Pro
Trp Ile Leu Pro
Trp Ile Pro Ile
Trp Ile Pro Leu
Trp Leu Ile Pro
Trp Leu Leu Pro
Trp Leu Pro Ile
Trp Leu Pro Leu
Trp Pro Ile Ile
Trp Pro Ile Leu
Trp Pro Leu Ile
Trp Pro Leu Leu
Trp Ser His Val
Trp Ser Val His
Trp Val His Ser
Trp Val Ser His
Tyr Ala Phe Lys
Tyr Ala Lys Phe
Tyr Phe Ala Lys
Tyr Phe Lys Ala
Tyr Lys Ala Phe
Tyr Lys Phe Ala
Fesoterodine Fumarate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D000089162 - Genitourinary Agents > D064804 - Urological Agents Fesoterodine Fumarate is an orally active, nonsubtype selective, competitive muscarinic receptor (mAChR) antagonist with pKi values of 8.0, 7.7, 7.4, 7.3, 7.5 for M1, M2, M3, M4, M5 receptors, respectively. Fesoterodine Fumarate is used for the overactive bladder (OAB)[1][2].
Gemcitabine elaidate
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor
Adenosine, N-acetyl-3,5-O-[1,1,3,3-tetrakis(1-Methylethyl)-1,3-disiloxanediyl]-
Morpholine-4-carboxylic acid (1-(3-benzenesulfonyl-1-phenethylallylcarbamoyl)-3-methylbutyl)-amide
(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl isobutyrate maleate
N-{3-[4-(3-Amino-propyl)-piperazin-1-YL]-propyl}-3-nitro-5-(galactopyranosyl)-beta-benzamide
N-{3-[4-(3-Amino-propyl)-piperazin-1-YL]-propyl}-3-nitro-5-(galactopyranosyl)-alpha-benzamide
(2S)-N-[(4S,4aR,6R,8S,8aR)-8-methoxy-7,7-dimethyl-6-[[(2R)-5-oxooxolan-2-yl]methyl]-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-4-yl]-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetamide
C26H41NO10 (527.2730326000001)
(2S,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
(2S,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
(2R,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
4-methoxy-N-[(5S,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H37N3O7 (527.2631372000001)
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
4-methoxy-N-[(5S,6S,9R)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H37N3O7 (527.2631372000001)
4-methoxy-N-[(5S,6S,9S)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H37N3O7 (527.2631372000001)
4-methoxy-N-[(5R,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H37N3O7 (527.2631372000001)
N-[(2S,4aS,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aR,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-4-ylacetamide
N-[(2R,4aS,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2R,4aS,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(2S,4aR,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
N-[(2S,4aS,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]oxane-4-carboxamide
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
C27H41N7O4 (527.3219866000001)
N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
(2S,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[(2R,4aR,12aS)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
2-((4R)-4-((3R,5S,7S,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2,2-dimethylpentanamido)ethane-1-sulfonic acid
C28H49NO6S (527.3280414000001)
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
C27H40F3N3O4 (527.2970756000001)
N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
C27H41N7O4 (527.3219866000001)
N-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
C27H41N7O4 (527.3219866000001)
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
C27H41N7O4 (527.3219866000001)
N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(propyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]methanesulfonamide
(2S,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2S,3S)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3S)-8-[(3R)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
(2R,3R)-8-[(3S)-3-hydroxybut-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(4-methylpent-1-ynyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
4-methoxy-N-[(5R,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H37N3O7 (527.2631372000001)
4-methoxy-N-[(5S,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H37N3O7 (527.2631372000001)
4-methoxy-N-[(5R,6S,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
C28H37N3O7 (527.2631372000001)
2-[[(5S,6R,9R)-5-methoxy-14-[(2-methoxy-1-oxoethyl)amino]-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-8-yl]methyl]benzoic acid
C28H37N3O7 (527.2631372000001)
N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylethanesulfonamide
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylethanesulfonamide
N-[(2R,4aR,12aR)-2-[2-(cyclohexylmethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-4-oxanecarboxamide
(3R,6aS,8R,10aS)-8-[2-(cyclohexylmethylamino)-2-oxoethyl]-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate
(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]hexadeca-4,8,12-triene-1-sulfonic acid
C28H49NO6S (527.3280414000001)
(4E,8E)-3-hydroxy-2-[[(4Z,7Z)-2-hydroxyhexadeca-4,7-dienoyl]amino]dodeca-4,8-diene-1-sulfonic acid
C28H49NO6S (527.3280414000001)
(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]tetradeca-4,8,12-triene-1-sulfonic acid
C28H49NO6S (527.3280414000001)
(4E,8E,12E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]pentadeca-4,8,12-triene-1-sulfonic acid
C28H49NO6S (527.3280414000001)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propan-2-yl] acetate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]propan-2-yl] butanoate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (4E,7E,10E,13E,16E)-docosa-4,7,10,13,16-pentaenoate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (7E,10E,13E,16E,19E)-docosa-7,10,13,16,19-pentaenoate
PE(22:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PC(19:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
LdMePE(20:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(18:5)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved